Are peptides legal in Maryland?

Can a Maryland resident get peptides by telehealth?

The Preserve Telehealth Access Act of 2021 added Health Occupations Article sections 1-1001 through 1-1006. Telehealth is defined to include both synchronous and asynchronous interactions, and an asynchronous interaction includes the secure transmission of medical information, clinical data, images, lab results, and self-reported medical history. Section 1-1003 requires a clinical evaluation before a practitioner provides telehealth services and states that the practitioner may use a synchronous or an asynchronous telehealth interaction to perform it; telehealth care is held to the same standard as in-person care. The stricter in-person assessment requirement in section 1-1003 applies only to certain controlled substances, such as Schedule II opioids. The Maryland Board of Physicians implements these rules for physicians in COMAR 10.32.05. The practitioner must be licensed in Maryland. Semaglutide, tirzepatide, and the other peptides in this database are not controlled substances, so federal telemedicine controlled substance rules do not apply. [2] [3] [4]

How does the Maryland pharmacy board treat compounding?

The Maryland Board of Pharmacy regulates pharmacists and pharmacies under Health Occupations Article, Title 12, and COMAR Title 10, Subtitle 34, including COMAR 10.34.19 on sterile pharmaceutical compounding. Maryland has no state bulks list; eligibility of a peptide for compounding follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Under Health Occupations section 12-403, a nonresident pharmacy that dispenses to Maryland patients must hold a Maryland pharmacy permit, submit the most recent inspection report from its home-state regulator, and designate a Maryland agent for service of process. Maryland no longer issues a separate sterile compounding permit: Chapter 5 of the Acts of 2015 (Senate Bill 69) repealed the sterile compounding permit requirement. Instead, section 12-403 requires a nonresident pharmacy that will dispense compounded sterile preparations to Maryland patients to submit a report of an inspection, conducted within 90 days before its application by a Board designee or another Board-approved entity, that shows compliance with USP chapter 797, and to keep complying with USP chapter 797 and the Board's sterile compounding regulations. COMAR 10.34.37.04 likewise requires a nonresident pharmacy that compounds sterile preparations to follow USP standards and COMAR 10.34.19. [1] [5] [6] [7] [8] [10]

Can you get compounded GLP-1s in Maryland?

Maryland's asynchronous telehealth rule makes app-based GLP-1 programs lawful on the prescribing side, but the dispensing pharmacy must still hold a Maryland pharmacy or nonresident pharmacy permit. [3] [5] [13]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Maryland?

Find a provider in Maryland

• Compounding pharmacies in Maryland
• Clinics in Maryland
• Telehealth providers in Maryland

Is it legal to buy research peptides in Maryland?

Maryland's Food, Drug, and Cosmetic Act (Health-General Article, Title 21) prohibits selling adulterated or misbranded drugs, and Health Occupations Title 12 limits dispensing of prescription drugs to permitted pharmacies and authorized practitioners. [1] [9] [14]

Peptide-specific notes for Maryland

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.